Redfund Capital Launches Beverage Products Division

Redfund Capital Launches Beverage Products Division - Cannabis Stocks News

VANCOUVER, British Columbia, Feb. 18, 2019 (GLOBE NEWSWIRE) – Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) (“Redfund” or the “Company”) launches new beverage division.

Within its global expansion plan, Redfund Capital is filling a key gap in the market for lifestyle-driven infused beverages as demand for upscale hospitality and health-wellness sectors start to boom. This foray of products will be the hemp market’s solution for the search of high quality items. Our products will be manufactured with the latest technology, where we have strategic alliances and where we will provide the raw materials.

The Company’s first beverage product group will consist of powdered flavored hemp seed and hemp infused teas. Hemp based protein powders have been popular as nutritional supplements used by athletes, bodybuilders and those looking to grow and stay healthy.

“Reports suggest the entire hemp-derived CBD market will hit $22 billion globally by 2022. Much of the focus on CBD-infused products and drinks is towards the healthy lifestyle consumer market. However, more big brand beverage companies are expected to enter the industry and create CBD-infused non-alcoholic beverages for a broader spectrum of consumers. CBD-focused developments and partnerships are likely to increase as industry regulation becomes clearer.” (CannabisNewsWire 1/15/19)

“The launch of our own proprietary beverage product-line has been in the works for almost a year. This division will provide the go forward business development advisory services as an added benefit to portfolio clients,” said Meris Kott, CEO.

About Redfund Capital

Redfund intends to provide debt and equity funding in the mid-to-late stages of a target company’s development, or in technologies that are developed and validated by revenues. The present focus of the merchant bank is on medical cannabis, hemp and CBD-related, healthcare-related target companies.

For further information please visit For more information on Redfund Capital contact Meris Kott CEO 604.484.8989 or Further information about the Company is available on under the Company’s profile.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain statements contained in this release may constitute “forward-looking statements” or “forward-looking information” (collectively “forward-looking information”) as those terms are used in the Private Securities Litigation Reform Act of 1995 and similar Canadian laws. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated”, “anticipates” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the business of the Company, the Property, financing and certain corporate changes. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

Get Real-Time Updates from The Daily Marijuana Observer

Source link

Additional Resources

Previous CannAmerica Signs LOI to Enter the European CBD Market
Next OTC Drug Manufacturer for CVS and Walgreens Launches Line of Hemp Supplements